286 related articles for article (PubMed ID: 24102431)
1. The application of induced pluripotent stem cells for bone regeneration: current progress and prospects.
Teng S; Liu C; Krettek C; Jagodzinski M
Tissue Eng Part B Rev; 2014 Aug; 20(4):328-39. PubMed ID: 24102431
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic antibody directed osteogenic differentiation of induced pluripotent stem cell derived MSCs.
Wu Q; Yang B; Cao C; Hu K; Wang P; Man Y
Acta Biomater; 2018 Jul; 74():222-235. PubMed ID: 29778895
[TBL] [Abstract][Full Text] [Related]
3. Embryonic stem cells and induced pluripotent stem cells for skeletal regeneration.
Park S; Im GI
Tissue Eng Part B Rev; 2014 Oct; 20(5):381-91. PubMed ID: 24206162
[TBL] [Abstract][Full Text] [Related]
4. Deriving Osteogenic Cells from Induced Pluripotent Stem Cells for Bone Tissue Engineering.
Wu Q; Yang B; Hu K; Cao C; Man Y; Wang P
Tissue Eng Part B Rev; 2017 Feb; 23(1):1-8. PubMed ID: 27392674
[TBL] [Abstract][Full Text] [Related]
5. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
6. iPSCs, aging and age-related diseases.
Isobe K; Cheng Z; Nishio N; Suganya T; Tanaka Y; Ito S
N Biotechnol; 2014 Sep; 31(5):411-21. PubMed ID: 24784583
[TBL] [Abstract][Full Text] [Related]
7. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
8. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
9. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
10. [Regenerative therapy for post-stroke patients].
Yamashita T; Abe K
Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
12. Stem cells combined with bone graft substitutes in skeletal tissue engineering.
Gamie Z; Tran GT; Vyzas G; Korres N; Heliotis M; Mantalaris A; Tsiridis E
Expert Opin Biol Ther; 2012 Jun; 12(6):713-29. PubMed ID: 22500826
[TBL] [Abstract][Full Text] [Related]
13. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.
Forostyak S; Jendelova P; Sykova E
Biochimie; 2013 Dec; 95(12):2257-70. PubMed ID: 23994163
[TBL] [Abstract][Full Text] [Related]
14. Impact of Induced Pluripotent Stem Cells in Bone Repair and Regeneration.
Rana D; Kumar S; Webster TJ; Ramalingam M
Curr Osteoporos Rep; 2019 Aug; 17(4):226-234. PubMed ID: 31256323
[TBL] [Abstract][Full Text] [Related]
15. Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration.
Illich DJ; Demir N; Stojković M; Scheer M; Rothamel D; Neugebauer J; Hescheler J; Zöller JE
Stem Cells; 2011 Apr; 29(4):555-63. PubMed ID: 21308867
[TBL] [Abstract][Full Text] [Related]
16. iPS cell technologies and cartilage regeneration.
Tsumaki N; Okada M; Yamashita A
Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells from iPS cells facilitate periodontal regeneration.
Hynes K; Menicanin D; Han J; Marino V; Mrozik K; Gronthos S; Bartold PM
J Dent Res; 2013 Sep; 92(9):833-9. PubMed ID: 23884555
[TBL] [Abstract][Full Text] [Related]
18. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
Iglesias-García O; Pelacho B; Prósper F
J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cells (iPSCs) as a new source of bone in reconstructive surgery: A systematic review and meta-analysis of preclinical studies.
Fliefel R; Ehrenfeld M; Otto S
J Tissue Eng Regen Med; 2018 Jul; 12(7):1780-1797. PubMed ID: 29763985
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cells from somatic cells.
Sohn YD; Han JW; Yoon YS
Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
